Reuters logo
3 个月前
BRIEF-Novo Nordisk launches Xultophy® 100/3.6 (insulin degludec and liraglutide injection) in U.S.
2017年5月3日 / 下午4点15分 / 3 个月前

BRIEF-Novo Nordisk launches Xultophy® 100/3.6 (insulin degludec and liraglutide injection) in U.S.

1 分钟阅读

May 3 (Reuters) - Novo Nordisk A/S :

* Launches Xultophy® 100/3.6 (insulin degludec and liraglutide injection) in United States Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below